Literature DB >> 2532509

The expression of canine cardiac phospholamban in heterologous systems.

E A Cook1, J P Huggins, G Sathe, P J England, J R Piggott.   

Abstract

A synthetic phospholamban gene has been cloned and expressed in Escherichia coli, producing both native phospholamban and a fusion protein with 81 amino acids of the influenza virus NS1 protein. Both the native phospholamban and fusion proteins produced extensive cell lysis upon induction of gene expression, but only the native protein underwent spontaneous pentamer formation in E. coli. Translation in vitro of mRNA produced by transcription in vitro of phospholamban cDNA was used to demonstrate the spontaneous aggregation of phospholamban to form pentamers in this system also, both in the presence and absence of exogenous microsomes from canine pancreas or heart. Phospholamban produced by translation in vitro was apparently susceptible to proteolysis by enzymes present in the particulate fractions in these experiments.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2532509      PMCID: PMC1133612          DOI: 10.1042/bj2640533

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  21 in total

1.  Purification and characterization of phospholamban from canine cardiac sarcoplasmic reticulum.

Authors:  L R Jones; H K Simmerman; W W Wilson; F R Gurd; A D Wegener
Journal:  J Biol Chem       Date:  1985-06-25       Impact factor: 5.157

2.  Localization of phospholamban in slow but not fast canine skeletal muscle fibers. An immunocytochemical and biochemical study.

Authors:  A O Jorgensen; L R Jones
Journal:  J Biol Chem       Date:  1986-03-15       Impact factor: 5.157

3.  Evidence for a phosphorylation-induced conformational change in phospholamban from the effects of three proteases.

Authors:  J P Huggins; P J England
Journal:  FEBS Lett       Date:  1987-06-08       Impact factor: 4.124

4.  Complete complementary DNA-derived amino acid sequence of canine cardiac phospholamban.

Authors:  J Fujii; A Ueno; K Kitano; S Tanaka; M Kadoma; M Tada
Journal:  J Clin Invest       Date:  1987-01       Impact factor: 14.808

5.  Purification and characterization of human H-ras proteins expressed in Escherichia coli.

Authors:  M Gross; R W Sweet; G Sathe; S Yokoyama; O Fasano; M Goldfarb; M Wigler; M Rosenberg
Journal:  Mol Cell Biol       Date:  1985-05       Impact factor: 4.272

6.  Isolation and characterization of canine cardiac sarcoplasmic reticulum with improved Ca2+ transport properties.

Authors:  B K Chamberlain; D O Levitsky; S Fleischer
Journal:  J Biol Chem       Date:  1983-05-25       Impact factor: 5.157

7.  Evidence for the presence of phospholamban in the endoplasmic reticulum of smooth muscle.

Authors:  L Raeymaekers; L R Jones
Journal:  Biochim Biophys Acta       Date:  1986-06-19

8.  Efficient expression of influenza virus NS1 nonstructural proteins in Escherichia coli.

Authors:  J F Young; U Desselberger; P Palese; B Ferguson; A R Shatzman; M Rosenberg
Journal:  Proc Natl Acad Sci U S A       Date:  1983-10       Impact factor: 11.205

9.  Purification and characterization of phospholamban from canine cardiac sarcoplasmic reticulum.

Authors:  M Inui; M Kadoma; M Tada
Journal:  J Biol Chem       Date:  1985-03-25       Impact factor: 5.157

10.  Sequence analysis of phospholamban. Identification of phosphorylation sites and two major structural domains.

Authors:  H K Simmerman; J H Collins; J L Theibert; A D Wegener; L R Jones
Journal:  J Biol Chem       Date:  1986-10-05       Impact factor: 5.157

View more
  2 in total

1.  Oligomeric interactions of sarcolipin and the Ca-ATPase.

Authors:  Joseph M Autry; John E Rubin; Sean D Pietrini; Deborah L Winters; Seth L Robia; David D Thomas
Journal:  J Biol Chem       Date:  2011-07-07       Impact factor: 5.157

2.  Characterization of the molecular form of cardiac phospholamban.

Authors:  J M Harrer; E G Kranias
Journal:  Mol Cell Biochem       Date:  1994-11-23       Impact factor: 3.396

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.